EU H2020 Project "CRYO2 (Telemetric control of oxygen delivery for therapy optimization and adherence)": description, partecipants, costs and EC-fundings

#	Pagina
attuale pagina	/open-h2020/projects/211475/index.html
-1	/open-h2020/per-topic/kafka/list/index.html
-2	/open-consip/fornitori/2015/profilo-01674940091/index.html
-3	/open-h2020/projects/198542/index.html
-4	/open-consip/fornitori/2017/profilo-01996010904/index.html
-5	/open-consip/fornitori/2018/profilo-06619201210/index.html
-6	/open-h2020/per-topic/workpackage/list/index.html
-7	/open-h2020/projects/196959/index.html
-8	/open-h2020/projects/226683/index.html
-9	/open-consip/fornitori/2021/profilo-01479700336/index.html

CryO2 project word cloud

Explore the words cloud of the CryO2 project. It provides you a very rough idea of what is the project "CryO2" about.

algorithm services prototype personal annually business telemetric distress wsn4life device poor integral worldwide sold upgraded follow opportunity regulation tested wireless facet position 13 estimate closely 30k consumption version care solution innovative medical 20 2018 provision remotely q4 disease flux home integration central sensor ltot 4 basis receive miniaturization patients commercial adherence industry global readily oxygen 30 telemedicine thinsp valuable envisage evolution reducing million service visits prevention trl vital source sensors 600 grade roi rising remote units 39 launch health hospitalization transform revenue therapy o2 72 signs strengthen flow 18k cryo2 4million solutions tanks automatic full base patient providers finalizing sign potentiating billion 2023 intensively monitoring pneumologists exacerbation intend telephone usa

Project "CryO2" data sheet

The following table provides information about the project.

Coordinator	WIRELESS SENSOR NETWORKS SRL Organization address address: VIA L. MANARA 31 city: MONZA postcode: 20900 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Italy [IT]
Project website	http://www.wsn4life.com
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.1.4. (Active ageing and self-management of health) 2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)) 3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 4. H2020-EU.3.1.6. (Health care provision and integrated care)
Code Call	H2020-SMEINST-1-2016-2017
Funding Scheme	SME-1
Starting year	2017
Duration (year-month-day)	from 2017-08-01 to 2017-11-30

#	participants	country	role	EC contrib. [€]
1	WIRELESS SENSOR NETWORKS SRL	IT (MONZA)	coordinator	50˙000.00

WIRELESS SENSOR NETWORKS SRL

IT (MONZA)

coordinator

50˙000.00

Project objective

'One million patients receive long-term oxygen therapy (LTOT) in the USA and 600,000 in EU with an estimated cost of €4 billion/year, rising 13% annually due to hospitalization and disease exacerbation for poor therapy adherence. Health care service providers try to increase their home-base services increasing personal visits to patients,and pneumologists try to closely follow-up patient#39;s therapy and disease evolution by telephone call. However, present solutions do not offer an integral solution able to remotely control every facet of patient#39;s management processes such as vital signs monitoring, automatic regulation of O2 flow from tanks and, telemetric therapy adherence. In WSN4LIFE, we have a 13-years valuable experience in medical device and telemedicine services and wireless sensor integration. Our innovative CRYO2 product will be offered to O2 source device sector as device and to health care service providers as telemedicine service. It will transform LTOT management, reducing distress for patients, reducing 20% hospitalization costs because of prevention in disease exacerbation and reducing by 30% the O2 consumption.Our TRL-6 prototype has been intensively tested to be readily upgraded in O2 tanks central unit. During the Phase 1 we intend to study its implementation by potentiating algorithm integration, sensors and central processing unit component miniaturization and finalizing test for remote O2 flux regulation. This will set the basis for a Phase 2 project development and launch a full commercial version by Q4 2018.We envisage CRYO2 being a great global business opportunity because no others solution offer our grade of vital sign integration and remote control. We estimate a 30k units sold and 18k service provided,a €5.4Million revenue and a ROI of 3.72 by 2023. CRYO2 will strengthen the global position of European medical device industry for oxygen therapy management and foster the home-based health care service provision for patients worldwide'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CRYO2" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CRYO2" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)